查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1600930

人類增強市場：按類型、功能、最終用途分類 - 2025-2030 年全球預測

Human Augmentation Market by Type (Augmented Reality Device, Biometric System, Exoskeletons), Functionality (Body Worn, Non-Body Worn), End-use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年人類增強市場的市場規模為2,558.4億美元，預計2024年將達到2,962.4億美元，複合年成長率為15.96%，到2030年將達到7,214.4億美元。

人類增強是指用於改善人類身體或認知方面的表現或表現的技術和技巧。廣泛的應用包括穿戴式裝置、外骨骼、腦機介面、基因增強等。該領域的驅動力是提高人類效率、健康和生活品質的需求，特別是在殘疾、醫療保健和勞動生產力領域。由於提高身體表現和決策能力的潛在好處，醫療保健和軍事領域是重要的最終用途領域。人類增強市場受到人工智慧、物聯網和奈米技術等技術進步的影響，為個人化醫療、增強學習環境和需要精確人機介面的產業創造了機會。科技巨頭投資的增加以及老年護理輔助設備需求的增加進一步提振了市場。然而，該領域面臨挑戰，包括道德問題、開發和實施的高成本以及可能減緩創新的嚴格法規結構。主要限制包括濫用技術的可能性和隱私問題，特別是在腦機介面方面。創新可以來自開發更實惠的穿戴式裝置和改進使用者介面系統。關於增強人工智慧更自然、更有效地解釋人類輸入的能力的研究正在蓬勃發展。透過專注於與醫療機構的聯合計劃，公司可以更好地將醫療需求和患者準備與技術進步結合起來。還有潛力探索人類增強，透過認知增強工具來提高創新產業和工人生產力。市場主要是創新主導的，是一個動態的格局，需要不斷適應新興技術、道德指南和消費者接受趨勢。透過專注於道德發展、成本效益和以使用者為中心的設計，公司可以最大限度地發揮人類增強的潛力，同時降低風險。

主要市場統計
基準年[2023] 2558.4億美元
預測年份 [2024] 2962.4億美元
預測年份 [2030] 7214.4億美元
複合年成長率（%） 15.96%

市場動態：揭示快速發展的人類增強市場的關鍵市場洞察

供需的動態交互作用正在改變人類增強市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 提高認知和身體增強應用的意識和接受度
    • 醫療穿戴式裝置對人類增強的需求不斷成長
    • 航太和國防對手勢追蹤的需求不斷成長
  • 市場限制因素
    • 開發人類增強技術成本高
  • 市場機會
    • 不斷介紹技術先進的人類增強
    • 政府支持與私人投資開發人類增強技術
  • 市場挑戰
    • 由於人類增強技術的使用而導致資料外洩和個人資訊外洩的風險

波特的五力：駕馭人類增強市場的策略工具

波特的五力框架是了解人類增強市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解人類增強市場的外部影響

外部宏觀環境因素在塑造人類增強市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解人類增強市場的競爭狀況

對人類增強市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣人類增強市場供應商績效評估

FPNV 定位矩陣是評估人類增強市場供應商的關鍵工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。四個象限清楚且準確地分類供應商，幫助使用者辨識最能滿足其策略目標的合作夥伴和解決方案。

本報告提供了涵蓋關鍵重點領域的全面市場分析：

1. 市場滲透率：對當前市場環境的詳細回顧，包括行業主要企業的廣泛資料。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 提高人們對可增強認知和身體表現的應用程式的認知和接受度
      • 醫療穿戴式裝置對人類增強的需求不斷成長
      • 航太和國防領域對手勢追蹤的需求不斷成長
    • 抑制因素
      • 開發人類增強技術的成本很高。
    • 機會
      • 不斷介紹技術先進的人類增強
      • 政府對技術開發的支持與私人投資
    • 任務
      • 由於使用人類增強技術而存在資料和個人資訊外洩的風險
  • 市場區隔分析
    • 類型：擴大擴增擴增實境設備的使用，提供免持資料存取和導航指導
    • 功能：更多使用穿戴式人類增強來提高活動能力和耐力
    • 最終用戶：擴大人類增強技術在製造業的應用，以提高工人的生產力和效率
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章人類增強市場：依類型

  • 擴增實境設備
  • 生物識別系統
  • 外骨骼
  • 智慧虛擬助理
  • 虛擬實境設備
  • 穿戴式裝置

第7章依功能分類的人類增強市場

  • 身體穿著
  • 非身體佩戴的

第8章人類增強市場：依最終用途分類

  • 航太和國防
  • 衛生保健
  • 製造業
  • 媒體與娛樂

第9章美洲人類增強市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區人類增強市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲的人類增強市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • Google和高通合作開發用於穿戴式裝置的 RISC-V 晶片
    • Vuzix 與廣達電腦簽署合作協議
    • Humane正式推出基於OpenAI的穿戴式設備“AI Pin”
    • 實現人與人之間的連結：Phantom Neuro 結合了人類增強和物聯網
    • 由 SFU 研究人員開發的 XoMotion 成為世界上最先進的外骨骼，適用於行動不便的人
    • 杜邦與意法半導體 (ST) 合作開發用於監測生物訊號的新型智慧穿戴裝置概念
    • 穿戴式裝置公司 Oura 收購數位身分Start-UpsProxy
    • 200 萬歐元資金用於新型人類增強創新，以增強人類的防禦能力
    • ARIA Research 獲得 140 萬美元津貼，在雪梨建立人類增強研究所
    • Ekso Bionics 宣布從 Parker Hannifin 公司收購人體運動與控制業務部門，包括 Indego 產品線
    • 京瓷在日本推出新的人類增強技術原型，配備先進的人工智慧以增強人類能力
    • Dasa 推出新的創新重點領域：人類增強(HA)
    • 巴黎Start-Ups籌集 4500 萬美元用於開發人類體外骨骼

公司名單

  • 3M Company
  • Amazon.com, Inc.
  • Apple Inc.
  • AppliedVR, Inc.
  • Aptima, Inc.
  • Atheer, Inc.
  • B-Temia Inc.
  • Charles River Analytics, Inc.
  • Cionic, Inc.
  • Cognitive Mill by AIHunters
  • Continental AG
  • CYBERDYNE Inc.
  • Ekso Bionics Holdings, Inc.
  • Esper Bionics Inc.
  • Fujitsu Limited
  • Garmin Limited
  • General Motors Company
  • Google LLC by Alphabet, Inc.
  • HID Global Corporation by Assa Abloy AB
  • Hocoma AG by DIH International Limited
  • HTC Corporation
  • Hyundai Motor Company
  • IDEMIA Group, SAS
  • Kyocera Corporation
  • Lifesense Group
  • Magic Leap Inc.
  • Meta Platforms, Inc.
  • Microsoft Corporation
  • NEC Corporation
  • Nvidia Corporation
  • Ottobock SE & Co. KGaA
  • Panasonic Corporation
  • Parker Hannifin Corporation
  • Rewalk Robotics Inc.
  • Rex Bionics Ltd
  • Robert Bosch GmbH
  • RTX Corporation
  • Saab AB
  • Samsung Electronics Co., Ltd.
  • Soar Technology, Inc.
  • Sony Group Corporation
  • Thales Group
  • Unity Software Inc.
  • Vuzix Corporation
Product Code: MRR-0355904475EC

The Human Augmentation Market was valued at USD 255.84 billion in 2023, expected to reach USD 296.24 billion in 2024, and is projected to grow at a CAGR of 15.96%, to USD 721.44 billion by 2030.

Human augmentation refers to the techniques and technologies used to enhance human capabilities and performance physically or cognitively. It encompasses a wide array of applications such as wearable gadgets, exoskeletons, brain-machine interfaces, and genetic enhancements. This field is driven by the necessity to improve human efficiency, health, and quality of life, especially in areas of disability, healthcare, and workforce productivity. Healthcare and military sectors represent significant end-use scopes due to the potential benefits of enhanced physical performance and decision-making capabilities. The market for human augmentation is influenced by advancements in technologies like AI, IoT, and nanotechnology, creating opportunities in personalized medicine, enhanced learning environments, and industries requiring precise human-machine interfaces. Growing investments from tech giants and the increasing demand for assistive devices in elder care further propel the market. However, this sector faces challenges such as ethical concerns, high costs of development and implementation, and stringent regulatory frameworks that may slow innovation. Key limitations include the potential for misuse of technology and privacy concerns, particularly with brain-machine interfaces. Innovations are likely in the development of more affordable wearable devices and improved user interface systems. Research is booming in enhancing AI capabilities to interpret human inputs more naturally and efficiently. Businesses could focus on collaborative projects with medical institutions to better align technological advancements with healthcare needs and patient acceptance. Additionally, there is potential to explore human augmentation in enhancing creative industries and workforce productivity through cognitive enhancement tools. The market is predominantly innovation-driven, with a dynamic landscape that requires constant adaptation to emerging technologies, ethical guidelines, and consumer acceptance trends. By focusing on ethical development, cost-effectiveness, and user-centric designs, businesses can harness the full potential of human augmentation while mitigating risks.

KEY MARKET STATISTICS
Base Year [2023] USD 255.84 billion
Estimated Year [2024] USD 296.24 billion
Forecast Year [2030] USD 721.44 billion
CAGR (%) 15.96%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Human Augmentation Market

The Human Augmentation Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing awareness and acceptance of cognitive and physical enhancement applications
    • Rising need for human augmentation for medical wearable devices
    • Increasing demand from aerospace & defense for gesture-tracking purposes
  • Market Restraints
    • High cost of development of human augmentation technologies
  • Market Opportunities
    • Continuous introduction of technologically advanced human augmentation
    • Government support and private investments for advancing human augmentation technologies
  • Market Challenges
    • Risk of data and identity breach with the usage of human augmentation technologies

Porter's Five Forces: A Strategic Tool for Navigating the Human Augmentation Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Human Augmentation Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Human Augmentation Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Human Augmentation Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Human Augmentation Market

A detailed market share analysis in the Human Augmentation Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Human Augmentation Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Human Augmentation Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Human Augmentation Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Amazon.com, Inc., Apple Inc., AppliedVR, Inc., Aptima, Inc., Atheer, Inc., B-Temia Inc., Charles River Analytics, Inc., Cionic, Inc., Cognitive Mill by AIHunters, Continental AG, CYBERDYNE Inc., Ekso Bionics Holdings, Inc., Esper Bionics Inc., Fujitsu Limited, Garmin Limited, General Motors Company, Google LLC by Alphabet, Inc., HID Global Corporation by Assa Abloy AB, Hocoma AG by DIH International Limited, HTC Corporation, Hyundai Motor Company, IDEMIA Group, S.A.S., Kyocera Corporation, Lifesense Group, Magic Leap Inc., Meta Platforms, Inc., Microsoft Corporation, NEC Corporation, Nvidia Corporation, Ottobock SE & Co. KGaA, Panasonic Corporation, Parker Hannifin Corporation, Rewalk Robotics Inc., Rex Bionics Ltd, Robert Bosch GmbH, RTX Corporation, Saab AB, Samsung Electronics Co., Ltd., Soar Technology, Inc., Sony Group Corporation, Thales Group, Unity Software Inc., and Vuzix Corporation.

Market Segmentation & Coverage

This research report categorizes the Human Augmentation Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Augmented Reality Device, Biometric System, Exoskeletons, Intelligent Virtual Assistants, Virtual Reality Device, and Wearable Device.
  • Based on Functionality, market is studied across Body Worn and Non-Body Worn.
  • Based on End-use, market is studied across Aerospace & Defense, Healthcare, Manufacturing, and Media & Entertainment.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing awareness and acceptance of cognitive and physical enhancement applications
      • 5.1.1.2. Rising need for human augmentation for medical wearable devices
      • 5.1.1.3. Increasing demand from aerospace & defense for gesture-tracking purposes
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of development of human augmentation technologies
    • 5.1.3. Opportunities
      • 5.1.3.1. Continuous introduction of technologically advanced human augmentation
      • 5.1.3.2. Government support and private investments for advancing human augmentation technologies
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of data and identity breach with the usage of human augmentation technologies
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Expanding usage of augmented reality devices to provide hands-free data access and navigation guidance
    • 5.2.2. Functionality: Increasing usage of body-worn human augmentation to enhance mobility and endurance
    • 5.2.3. End-user: Increasing application of human augmentation technologies in the manufacturing sector to improve worker productivity and efficiency
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Human Augmentation Market, by Type

  • 6.1. Introduction
  • 6.2. Augmented Reality Device
  • 6.3. Biometric System
  • 6.4. Exoskeletons
  • 6.5. Intelligent Virtual Assistants
  • 6.6. Virtual Reality Device
  • 6.7. Wearable Device

7. Human Augmentation Market, by Functionality

  • 7.1. Introduction
  • 7.2. Body Worn
  • 7.3. Non-Body Worn

8. Human Augmentation Market, by End-use

  • 8.1. Introduction
  • 8.2. Aerospace & Defense
  • 8.3. Healthcare
  • 8.4. Manufacturing
  • 8.5. Media & Entertainment

9. Americas Human Augmentation Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Human Augmentation Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Human Augmentation Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Google and Qualcomm Partner to Make RISC-V Chip for Wearable Devices
    • 12.3.2. Vuzix Enters into a Partnership Agreement with Quanta Computer
    • 12.3.3. Humane Officially Launches the AI Pin, its OpenAI-powered Wearable
    • 12.3.4. Enabling Human Connectivity: Phantom Neuro Merges Human Augmentation and IoT
    • 12.3.5. XoMotion Created by SFU Researchers to be World's most Advanced Exoskeleton for Mobility Challenged
    • 12.3.6. DuPont Collaborates with STMicroelectronics (ST) to Develop New Smart Wearable Device Concept for Monitoring Biosignals
    • 12.3.7. Wearable Company Oura Acquires Digital Identification Startup Proxy
    • 12.3.8. EUR 2 Million Funding for Novel Human Augmentation Innovations to Enhance Human Capability in Defense
    • 12.3.9. ARIA Research Receives USD 1.4 Million in Grant Funding to Build Human Augmentation Laboratory in Sydney
    • 12.3.10. Ekso Bionics Announces Acquisition of Human Motion and Control Business Unit Including Indego Product Line from Parker Hannifin Corporation
    • 12.3.11. KYOCERA Introduces New Human Augmentation Technology Prototypes in Japan with Advanced AI to Enhance Human Abilities
    • 12.3.12. Dasa Launches New Innovation Focus Area: Human Augmentation (HA)
    • 12.3.13. A Parisian Startup just Raised USD 45 Million to Build Human Exoskeletons

Companies Mentioned

  • 1. 3M Company
  • 2. Amazon.com, Inc.
  • 3. Apple Inc.
  • 4. AppliedVR, Inc.
  • 5. Aptima, Inc.
  • 6. Atheer, Inc.
  • 7. B-Temia Inc.
  • 8. Charles River Analytics, Inc.
  • 9. Cionic, Inc.
  • 10. Cognitive Mill by AIHunters
  • 11. Continental AG
  • 12. CYBERDYNE Inc.
  • 13. Ekso Bionics Holdings, Inc.
  • 14. Esper Bionics Inc.
  • 15. Fujitsu Limited
  • 16. Garmin Limited
  • 17. General Motors Company
  • 18. Google LLC by Alphabet, Inc.
  • 19. HID Global Corporation by Assa Abloy AB
  • 20. Hocoma AG by DIH International Limited
  • 21. HTC Corporation
  • 22. Hyundai Motor Company
  • 23. IDEMIA Group, S.A.S.
  • 24. Kyocera Corporation
  • 25. Lifesense Group
  • 26. Magic Leap Inc.
  • 27. Meta Platforms, Inc.
  • 28. Microsoft Corporation
  • 29. NEC Corporation
  • 30. Nvidia Corporation
  • 31. Ottobock SE & Co. KGaA
  • 32. Panasonic Corporation
  • 33. Parker Hannifin Corporation
  • 34. Rewalk Robotics Inc.
  • 35. Rex Bionics Ltd
  • 36. Robert Bosch GmbH
  • 37. RTX Corporation
  • 38. Saab AB
  • 39. Samsung Electronics Co., Ltd.
  • 40. Soar Technology, Inc.
  • 41. Sony Group Corporation
  • 42. Thales Group
  • 43. Unity Software Inc.
  • 44. Vuzix Corporation

LIST OF FIGURES

  • FIGURE 1. HUMAN AUGMENTATION MARKET RESEARCH PROCESS
  • FIGURE 2. HUMAN AUGMENTATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL HUMAN AUGMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. HUMAN AUGMENTATION MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. HUMAN AUGMENTATION MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. HUMAN AUGMENTATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL HUMAN AUGMENTATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. HUMAN AUGMENTATION MARKET DYNAMICS
  • TABLE 7. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY AUGMENTED REALITY DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY BIOMETRIC SYSTEM, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY EXOSKELETONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY INTELLIGENT VIRTUAL ASSISTANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY VIRTUAL REALITY DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY WEARABLE DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY BODY WORN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY NON-BODY WORN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY AEROSPACE & DEFENSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL HUMAN AUGMENTATION MARKET SIZE, BY MEDIA & ENTERTAINMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. ARGENTINA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 31. BRAZIL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES HUMAN AUGMENTATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 46. AUSTRALIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. AUSTRALIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 48. AUSTRALIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. CHINA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CHINA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 51. CHINA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. INDIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. INDIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 54. INDIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. INDONESIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. INDONESIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 57. INDONESIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. JAPAN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. JAPAN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 60. JAPAN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. MALAYSIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. MALAYSIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 63. MALAYSIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. PHILIPPINES HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. PHILIPPINES HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 66. PHILIPPINES HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. SINGAPORE HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. SINGAPORE HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 69. SINGAPORE HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. SOUTH KOREA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. SOUTH KOREA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 72. SOUTH KOREA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. TAIWAN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. TAIWAN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 75. TAIWAN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. THAILAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. THAILAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 78. THAILAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. VIETNAM HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. VIETNAM HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 81. VIETNAM HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA HUMAN AUGMENTATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 86. DENMARK HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. DENMARK HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 88. DENMARK HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. EGYPT HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. EGYPT HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 91. EGYPT HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. FINLAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. FINLAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 94. FINLAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. FRANCE HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. FRANCE HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 97. FRANCE HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. GERMANY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. GERMANY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 100. GERMANY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. ISRAEL HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. ISRAEL HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 103. ISRAEL HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. ITALY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. ITALY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 106. ITALY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. NETHERLANDS HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. NETHERLANDS HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 109. NETHERLANDS HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 110. NIGERIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. NIGERIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 112. NIGERIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. NORWAY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. NORWAY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 115. NORWAY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. POLAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. POLAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 118. POLAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. QATAR HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. QATAR HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 121. QATAR HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. RUSSIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. RUSSIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 124. RUSSIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. SAUDI ARABIA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. SAUDI ARABIA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 127. SAUDI ARABIA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. SOUTH AFRICA HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. SOUTH AFRICA HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 130. SOUTH AFRICA HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 131. SPAIN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. SPAIN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 133. SPAIN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 134. SWEDEN HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. SWEDEN HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 136. SWEDEN HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. SWITZERLAND HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. SWITZERLAND HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 139. SWITZERLAND HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. TURKEY HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. TURKEY HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 142. TURKEY HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED ARAB EMIRATES HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED ARAB EMIRATES HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED ARAB EMIRATES HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 146. UNITED KINGDOM HUMAN AUGMENTATION MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. UNITED KINGDOM HUMAN AUGMENTATION MARKET SIZE, BY FUNCTIONALITY, 2018-2030 (USD MILLION)
  • TABLE 148. UNITED KINGDOM HUMAN AUGMENTATION MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 149. HUMAN AUGMENTATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 150. HUMAN AUGMENTATION MARKET, FPNV POSITIONING MATRIX, 2023